Leptin promotes human glioblastoma growth through activating Signal Transducers and Activators of Transcription 3 signaling

Leptin plays an important role in cancer development and progression. However, its role on human glioblastoma cell line U87 growth and the underlying mechanism remains unexplored. In this study, we assessed the effect of leptin on U87 cells proliferation in vitro and in vivo, elucidating its underlying mechanism. The results showed that leptin significantly promoted U87 tumor cells growth in a time-and-dose-dependent manner. Leptin increased cell DNA synthesis and promoted G0/G1 phase to S phase transition, but without any influence on cell apoptosis. In addition, leptin treatment resulted in phosphorylation of Signal Transducers and Activators of Transcription 3 (STAT3) on Tyr705, the key transcription factor in Janus-Activated Kinase (JAK)/STAT3 signaling pathway. All the data suggest that the JAK/STAT3 signaling pathway may be involved in promoting U87 glioblastoma growth mediated by leptin, which may be a target for anti-neoplastic treatments for glioblastoma.

► We assess the effect of leptin on U87 cells proliferation in vitro and in vivo, and elucidate its underlying mechanism. ► Leptin significantly promoted U87 tumor cells growth as a time- and dose-dependent. ► Leptin increased cell DNA synthesis and promoted G0/G1 phase to S phase transition, while there was no any influence on cell apoptosis. ► Leptin treatment resulted in phosphorylation of Signal Transducers and Activators of Transcription 3 (pSTAT3).